| Jeffrey Gorelick, MD | |
|
51-53 Kenosia Ave, Danbury, CT 06810 | |
| (203) 748-0330 | |
| (203) 731-3273 |
| Full Name | Jeffrey Gorelick |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 41 Years |
| Location | 51-53 Kenosia Ave, Danbury, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538164736 | NPI | - | NPPES |
| 1296575 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 029657 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Danbury Hospital | Danbury, CT | Hospital |
| Yale-new Haven Hospital | New haven, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Urology Associates Of Danbury, Pc | 3971494782 | 10 |
News Archive
Over the last two decades, there has been a rise in head and neck cancers in the oropharynx, a region in the back of the throat that includes the tonsils and the base of the tongue.
Neonatal concentrations of eight detectable inflammatory markers were significantly different in children later diagnosed with B-cell precursor acute lymphoblastic leukemia (ALL) compared with controls.
Isis Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 clinical study for ISIS-APOARx, an antisense drug targeting apolipoprotein(a) for the treatment of atherosclerosis.
New research released today in Nature Neuroscience reveals for the first time that pain is processed in male and female mice using different cells. These findings have far-reaching implications for our basic understanding of pain, how we develop the next generation of medications for chronic pain—which is by far the most prevalent human health condition—and the way we execute basic biomedical research using mice.
Thomson Reuters announced today that it has launched The Outpartnering Registry, an innovative resource designed to change the way biotechnology, pharmaceutical and academic organizations find partnering opportunities around the world.
› Verified 8 days ago
| Entity Name | Danbury Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548293343 PECOS PAC ID: 1557273935 Enrollment ID: O20031104000476 |
News Archive
Over the last two decades, there has been a rise in head and neck cancers in the oropharynx, a region in the back of the throat that includes the tonsils and the base of the tongue.
Neonatal concentrations of eight detectable inflammatory markers were significantly different in children later diagnosed with B-cell precursor acute lymphoblastic leukemia (ALL) compared with controls.
Isis Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 clinical study for ISIS-APOARx, an antisense drug targeting apolipoprotein(a) for the treatment of atherosclerosis.
New research released today in Nature Neuroscience reveals for the first time that pain is processed in male and female mice using different cells. These findings have far-reaching implications for our basic understanding of pain, how we develop the next generation of medications for chronic pain—which is by far the most prevalent human health condition—and the way we execute basic biomedical research using mice.
Thomson Reuters announced today that it has launched The Outpartnering Registry, an innovative resource designed to change the way biotechnology, pharmaceutical and academic organizations find partnering opportunities around the world.
› Verified 8 days ago
| Entity Name | Urology Associates Of Danbury, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932107034 PECOS PAC ID: 3971494782 Enrollment ID: O20041005000080 |
News Archive
Over the last two decades, there has been a rise in head and neck cancers in the oropharynx, a region in the back of the throat that includes the tonsils and the base of the tongue.
Neonatal concentrations of eight detectable inflammatory markers were significantly different in children later diagnosed with B-cell precursor acute lymphoblastic leukemia (ALL) compared with controls.
Isis Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 clinical study for ISIS-APOARx, an antisense drug targeting apolipoprotein(a) for the treatment of atherosclerosis.
New research released today in Nature Neuroscience reveals for the first time that pain is processed in male and female mice using different cells. These findings have far-reaching implications for our basic understanding of pain, how we develop the next generation of medications for chronic pain—which is by far the most prevalent human health condition—and the way we execute basic biomedical research using mice.
Thomson Reuters announced today that it has launched The Outpartnering Registry, an innovative resource designed to change the way biotechnology, pharmaceutical and academic organizations find partnering opportunities around the world.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Gorelick, MD 51-53 Kenosia Ave, Danbury, CT 06810 Ph: (203) 748-0300 | Jeffrey Gorelick, MD 51-53 Kenosia Ave, Danbury, CT 06810 Ph: (203) 748-0330 |
News Archive
Over the last two decades, there has been a rise in head and neck cancers in the oropharynx, a region in the back of the throat that includes the tonsils and the base of the tongue.
Neonatal concentrations of eight detectable inflammatory markers were significantly different in children later diagnosed with B-cell precursor acute lymphoblastic leukemia (ALL) compared with controls.
Isis Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 clinical study for ISIS-APOARx, an antisense drug targeting apolipoprotein(a) for the treatment of atherosclerosis.
New research released today in Nature Neuroscience reveals for the first time that pain is processed in male and female mice using different cells. These findings have far-reaching implications for our basic understanding of pain, how we develop the next generation of medications for chronic pain—which is by far the most prevalent human health condition—and the way we execute basic biomedical research using mice.
Thomson Reuters announced today that it has launched The Outpartnering Registry, an innovative resource designed to change the way biotechnology, pharmaceutical and academic organizations find partnering opportunities around the world.
› Verified 8 days ago
William T. Hennessy, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 51-53 Kenosia Ave, Danbury, CT 06810 Phone: 203-748-0330 Fax: 203-731-3273 | |
Edward M Beck, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 51-53 Kenosia Ave, Danbury, CT 06810 Phone: 203-748-0330 Fax: 203-731-3273 | |
Stanford R Broder, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 51-53 Kenosia Ave, Danbury, CT 06810 Phone: 203-748-0330 Fax: 203-731-3273 | |
John James Bruno Ii, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 51-53 Kenosia Ave, Danbury, CT 06810 Phone: 203-748-0330 Fax: 203-731-3273 | |
Alex Michael Hennessey, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 51-53 Kenosia Ave, Danbury, CT 06810 Phone: 203-748-0330 |